Sonoma Biotherapeutics
PrivateLast Round
Strategic
Mar 28, 2023
Total Funding Raised
$365M
Company Overview
Sonoma Biotherapeutics is a biotechnology company that develops T-cell therapeutics aimed at curing autoimmune and degenerative diseases by promoting self-tolerance and reducing harmful inflammatory responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonoma Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Sonoma Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 28, 2023 | ||||
| Series B | Aug 4, 2021 | ||||
| Series A Extension | Sep 30, 2020 | ||||
| Series A | Feb 6, 2020 |
Sonoma Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B |
| Frazier Healthcare Partners | Series B |
| Vertex Ventures HC | Series B |
| GV | Series B |
| Mirae Asset | Series B |
| Octagon Capital Advisors | Series B, Series A Extension |
| Ally Bridge Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2025
Expediting G-Rex manufacturing process for autoimmune disorder therapies.
- Aug 26, 2025
Lisa Taylor Ash appointed as new Chief Legal Officer.
Sonoma Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sonoma Biotherapeutics's valuation, stock price, and market status.
